1 이가희, "대한갑상선학회 갑상선결절 및 암 진료 권고안 개정안" 대한내분비학회 25 (25): 270-297, 2010
2 정찬권, "갑상샘 세침흡인세포검사 판독에 있어 베데스다 시스템의 적용" 대한병리학회 44 (44): 521-527, 2010
3 Garcia-Rostan G, "ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer" 21 (21): 3226-3235, 2003
4 Kim SK, "Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status" 96 (96): 658-664, 2011
5 Manenti G, "Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas" 30 (30): 987-993, 1994
6 Marotta V, "RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint" 165 (165): 499-507, 2011
7 Yeo MK, "Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules" 75 (75): 555-560, 2011
8 Monzani F, "Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis?" 13 (13): 389-394, 2003
9 Basolo F, "N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression" 10 (10): 19-23, 2000
10 Jung CK, "Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma" 22 (22): 791-797, 2012
1 이가희, "대한갑상선학회 갑상선결절 및 암 진료 권고안 개정안" 대한내분비학회 25 (25): 270-297, 2010
2 정찬권, "갑상샘 세침흡인세포검사 판독에 있어 베데스다 시스템의 적용" 대한병리학회 44 (44): 521-527, 2010
3 Garcia-Rostan G, "ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer" 21 (21): 3226-3235, 2003
4 Kim SK, "Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status" 96 (96): 658-664, 2011
5 Manenti G, "Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas" 30 (30): 987-993, 1994
6 Marotta V, "RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint" 165 (165): 499-507, 2011
7 Yeo MK, "Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules" 75 (75): 555-560, 2011
8 Monzani F, "Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis?" 13 (13): 389-394, 2003
9 Basolo F, "N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression" 10 (10): 19-23, 2000
10 Jung CK, "Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma" 22 (22): 791-797, 2012
11 Nikiforov YE, "Molecular genetics and diagnosis of thyroid cancer" 7 (7): 569-580, 2011
12 Eszlinger M, "Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns" 322 (322): 29-37, 2010
13 Nikiforov YE, "Molecular diagnostics of thyroid tumors" 135 (135): 569-577, 2011
14 Chudova D, "Molecular classification of thyroid nodules using high-dimensionality genomic data" 95 (95): 5296-5304, 2010
15 Nikiforov YE, "Molecular analysis of thyroid tumors" 24 (24): 34-43, 2011
16 Piana S, "Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007" 22 (22): 164-173, 2011
17 Nikiforov YE, "Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples" 96 (96): 3390-3397, 2011
18 Henry MR, "Follicular neoplasm/ suspicious for a follicular neoplasm, In The Bethesda system for reporting thyroid cytopathology" 51-58, 2010
19 Kapur U, "Follicular neoplasm of the thyroid-- vanishing cytologic diagnosis?" 35 (35): 525-528, 2007
20 Sobrinho-Simoes M, "Follicular carcinoma, In World Health Organization classification of tumours. Pathology and genetics: Tumours of endocrine organs" IARC Press 67-76, 2004
21 Nikiforov YE, "Follicular carcinoma, In Diagnostic pathology and molecular genetics of the thyroid" Lipppincott Williams & Wilkins 132-159, 2009
22 Chung KW, "Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area" 65 (65): 660-666, 2006
23 Ferraz C, "Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules" 96 (96): 2016-2026, 2011
24 Paunovic I, "Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors" 120 (120): 368-379, 2012
25 이승태, "Clinical Implication of Highly Sensitive Detection of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules: A Comparative Analysis of Three Molecular Assays in 4585 Consecutive Cases in a BRAF V600E Mutation-Prevalent Area" ENDOCRINE SOC 97 (97): 2299-2306, 201207
26 Kim SW, "BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population" 95 (95): 3693-3700, 2010
27 Nam SY, "BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis" 20 (20): 273-279, 2010
28 Gharib H, "American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules" 16 (16): 1-43, 2010